The Tripledemic, Disease Awareness and More Health News Trends
A look at the health news from PR Newswire in November and December that you might have missed.
(Note: This is an edited version of a blog post originally published on prnewswire.com. Read the original for more.)
Healthcare is always a popular topic for press releases sent via PR Newswire. The announcements cover everything from FDA approvals and new medicines to AI and wellness products. For example, more than 5,900 healthcare-focused releases went out via PR Newswire in November and December alone.
Among those health news releases, we noticed a few persisting trends throughout the end of 2022– especially flu season, which escalated to the tripledemic. The majority of the trends we noticed in November and December also shared a common positive theme: advances in medicine, especially through new drug treatments that offered promise heading into the new year.
Let’s take a look at the healthcare trends we noticed over the two-month period that closed out 2022.
Some of the Most Popular Health News Headlines:
Of the health headlines to cross the wire in November and December, these ones received a standout number of reads and/or engagement:
- One of the most popular health-related releases from the last two months of the year was about pet health. A Golden Retriever named Pippa was poisoned after eating unbaked bread rolls meant for Thanksgiving dinner. Luckily, she made a full recovery!
- Big news in healthcare acquisitions came in December when the biotechnology company Amgen announced its plans to acquire Horizon Therapeutics plc.
- Planet Fitness and Amazon Halo came together in November to help people on their fitness journeys. The collaboration provided new members with a complimentary Amazon Halo View wellness tracker.
Healthcare News Trends
Here’s a look at a few of the trends we noticed among healthcare-related press releases in November and December, with a few examples of each.
Ah…ah…AHCOO! It’s that time of year when you hear coughing and sneezing everywhere you go. Is it the flu? Or something else?
We kept hearing the term “tripledemic” in November and December in the news and press releases. What is the tripledemic? It’s the number of patients suffering from COVID, the flu, and RSV all surging at the same time. This has been overwhelming for doctors’ offices, hospitals, and even drug stores, which are suffering from a shortage of some over-the-counter medicines. This led to high hospital bed occupancies and stores limiting purchases of some medications.
November and December saw 183 press releases mentioning “tripledemic,” “RSV,” or “flu” sent via PR Newswire, compared to 130 in September and October, a 40% increase. In addition, press releases mentioning all 3 illnesses together (RSV, flu, and COVID) jumped 966%.
Here are a few examples from November and December:
- Summer Health Adds Messaging-Based Pediatric Care Initiative to Combat the RSV, Flu, and COVID “Tripledemic”
- Tripledemic Leaves Consumers Scrambling for Solutions
- New Survey Shows Many Americans Are Confused by Testing Options for COVID-19 and Flu
If that wasn’t enough, late in December the CDC alerted the medical community that it was seeing an increase in Strep A cases in children as well. We’ll keep an eye on this developing trend in the coming months.
American Diabetes Month
American Diabetes Month occurs every November and organizations seek to raise awareness, educate the public, and provide resources about all things diabetes.
Plenty of material was sent over the wire in November and December related to diabetes awareness, detection, and care:
- Beyond Type 1 and Nick Jonas Launch #SeeTheSigns Campaign for World Diabetes Day 11/14
- FDA Approves First Drug That Can Delay Onset of Type 1 Diabetes
- Diabetes is Up 15% Nationwide in Past 10 Years
World AIDS Day
World AIDS Day is celebrated on December 1 of each year. According to the World AIDS Day website, 38 million people have the virus across the globe. And since its identification in 1984, HIV and AIDS-related sicknesses have claimed the lives of 35 million people.
In the final months of 2022, PR Newswire distributed some noteworthy releases regarding this important ongoing public health issue:
- FDA Approves New HIV Drug for Adults with Limited Treatment Options
- MISTR Expands Telehealth Platform to Include Long-Term HIV Care
- World AIDS Day Brings to Light AIDS Epidemic’s Disproportionate Impact on Black and Brown Lives
Alzheimer’s Disease Awareness
According to the Alzheimer’s Association, more than 6 million Americans are living with Alzheimer’s. PR Newswire sent out 162 press releases in November and December that mentioned “Alzheimer’s.”
There were a couple of events that led to an uptick in mentions of “Alzheimer’s disease” in press releases in the November-December timeframe. First, November is Alzheimer’s Disease Awareness Month in the U.S. Also, the Clinical Trials and Alzheimer’s Disease Conference (CTAD) was held November 29-December 2 in San Francisco. Many of the press releases from CTAD mentioned the promise of the Alzheimer’s drug lecanemab, which hopes to slow down the progression of the disease. This new treatment received FDA approval on Jan. 6, 2023.
Examples from the last two months of 2022:
- Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity AD Study for Early Alzheimer’s Disease at CTAD
- Gene Mutation May Explain Brain Cell Plaque Buildup in Alzheimer’s Disease
- Edward Jones Announces Significant Progress Toward Its $50 Million Commitment To Help Find a Cure for Alzheimer’s
- Cure Alzheimer’s Fund Honors the Scientists Working to Find a Cure
November and December saw a focus on several severe diseases that impact millions of Americans: AIDS, Alzheimer’s Disease, and diabetes. Along with this, the healthcare industry ended 2022 with some very important topics and discoveries. 2023 will be more of the same with even more innovations in healthcare happening every day. Health will also continue to be on the minds of consumers into the new year as many people start 2023 with a focus on fitness and wellness.